News

Yahoo Finance16d
U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich
for XIFAXAN ® (rifaximin) 550 mg and failure to determine Teva Pharmaceuticals USA, Inc. (Teva) had forfeited its 180-day exclusivity were arbitrary, capricious, and contrary to law. Norwich ...
PharmiWeb16d
U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich
for XIFAXAN ® (rifaximin) 550 mg and failure to determine Teva Pharmaceuticals USA, Inc. (Teva) had forfeited its 180-day exclusivity were arbitrary, capricious, and contrary to law. Norwich sought an ...
Finanznachrichten15d
Bausch Health Companies Inc.: U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich
for XIFAXAN ® (rifaximin) 550 mg and failure to determine Teva Pharmaceuticals USA, Inc. (Teva) had forfeited its 180-day exclusivity were arbitrary, capricious, and contrary to law. Norwich sought an ...